Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Operating activities
Net income	$ 95,015	$ 66,331
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation	71,025	77,091
Amortization of intangible and other assets and favorable/unfavorable leases	2,132	1,946
Amortization of long-term prepaid rents	1,310	1,284
Amortization of debt issue costs	2,386	2,371
Amortization of deferred revenues, deferred lease incentives and other	(4,544)	(4,798)
Amortization of accumulated other comprehensive loss related to interest rate swap agreement	1,976	2,259
Fair value change in interest rate swap agreements not designated as hedges	(567)	(328)
Amortization of bond discount	456	417
Impairment of long-lived assets	496	2,609
Share based awards compensation expense	6,868	4,572
Loss on sale of assets and other	1,305	5,128
Loss on contribution and sale of digital projection systems to DCIP		1,038
Loss on early retirement of debt		4,945
Deferred lease expenses	2,330	1,650
Deferred income tax expenses	(3,993)	5,881
Equity in loss of affiliates	(2,778)	(634)
Distributions from equity investees	2,803	2,835
Changes in assets and liabilities	(844)	7,151
Net cash provided by operating activities	175,376	181,748
Investing activities
Additions to theatre properties and equipment	(93,587)	(85,302)
Proceeds from sale of theatre properties and equipment	667	4,471
Investment in DCIP and other	(406)	(993)
Net cash used for investing activities	(107,406)	(81,824)
Financing activities
Proceeds from stock option exercises	2	444
Payroll taxes paid as a result of restricted stock withholdings	(3,263)	(494)
Dividends paid to stockholders	(48,106)	(47,873)
Repayments of long-term debt	(6,052)	(162,254)
Proceeds from issuance of senior subordinated notes		200,000
Payment of debt issue costs		(4,521)
Payments on capital leases	(4,598)	(3,495)
Purchase of noncontrolling interest in Cinemark Chile		(1,443)
Other	231	(191)
Net cash used for financing activities	(61,786)	(19,827)
Effect of exchange rate changes on cash and cash equivalents	(3,310)	5,810
Increase in cash and cash equivalents	2,874	85,907
Cash and cash equivalents:
Beginning of period	521,408	464,997
End of period	524,282	550,904
UNITED STATES
Investing activities
Acquisition of theatre in U.S.	$ (14,080)